Coleman, L.J.;                     Byrne, J.L.;                     Edwards, S.;                     O’Hara, R.    
        Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective. LabMed 2025, 2, 8.
    https://doi.org/10.3390/labmed2020008
    AMA Style
    
                                Coleman LJ,                                 Byrne JL,                                 Edwards S,                                 O’Hara R.        
                Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective. LabMed. 2025; 2(2):8.
        https://doi.org/10.3390/labmed2020008
    
    Chicago/Turabian Style
    
                                Coleman, Laura Jane,                                 John L. Byrne,                                 Stuart Edwards,                                 and Rosemary O’Hara.        
                2025. "Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective" LabMed 2, no. 2: 8.
        https://doi.org/10.3390/labmed2020008
    
    APA Style
    
                                Coleman, L. J.,                                 Byrne, J. L.,                                 Edwards, S.,                                 & O’Hara, R.        
        
        (2025). Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective. LabMed, 2(2), 8.
        https://doi.org/10.3390/labmed2020008